FindTrial
Sign In

A cohort study on the relationship of gut microbiome with levels of neutralising serum antibodies after the COVID-19 vaccination in human bodies

A cohort study on the relationship of gut microbiome and levels of neutralising serum antibodies after the COVID-19 vaccination

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047218
Enrollment
Unknown
Registered
2021-06-11
Start date
2021-04-27
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case Series:NO

Sponsors

Zhujiang Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy population suited for COVID-19 vaccine

Exclusion criteria

Exclusion criteria: Persons with the key information lost in COVID-19 vaccination informed consent form; Persons who refused to sign the informed consent form and participate in this study; Persons with mental or neurological disorders; Persons who were judged inappropriate to participate in the research by the researcher.

Design outcomes

Primary

MeasureTime frame
Serum total antibodies;Serum neutralizing antibodies;gut microbiome;—

Secondary

MeasureTime frame
phenotypes of immune cells;—

Countries

China

Contacts

Public ContactZHOU Hongwei

Zhujiang Hospital

hzhou@smu.edu.cn+86 020-62783355

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026